Published in Cancer Weekly, February 8th, 2005
"Mutations in the breast cancer susceptibility gene BRCA1 account for a significant proportion of hereditary breast and ovarian cancers. Cofactor of BRCA1 (COBRA1) was isolated as a BRCA1-interacting protein and exhibited a similar chromatin reorganizing activity to that of BRCA1. However, the biological role of COBRA1 remains largely unexplored," wrote H.J. Zhong and colleagues, Beijing Institute of Biotechnology.
In experiments by these researchers, "ectopic expression of COBRA1 inhibited activator protein 1 (AP-1)...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.